N/A N=45 Randomized Single-blind Treatment

Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety

Public Speaking · Social Fear

Bottom Line

View on ClinicalTrials.gov: NCT00842946 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2014

Primary outcome: Primary: Number of Participants in Remission (Per Structured Clinical Interview for DSM-IV Axis I Disorders (SCID)) — 21; 20 participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Exposure w/ Acceptance-Based Rationale (Behavioral); Exposure w/ Habituation-Based Rationale (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Drexel University
Primary completion: Nov 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants in Remission (Per Structured Clinical Interview for DSM-IV Axis I Disorders (SCID))	21; 20	—

Summary

The purpose of this study is to compare two exposure-based behavioral group treatments for public speaking anxiety. Specifically, exposure within the context of psychological acceptance will be compared to exposure within a standard habituation context. It is hypothesized that participants receiving exposure within the context of psychological acceptance will experience a greater decrease in anxiety and greater improvement in quality of life compared to the habituation-based group.

Eligibility Criteria

Inclusion Criteria

Clinically diagnosable public speaking anxiety (per DSM-IV-TR criteria for nongeneralized social anxiety disorder)
Aged 18-65
Residence in the greater Philadelphia area

Exclusion Criteria

Pervasive developmental disability
Acute suicide potential
Inability to travel to the treatment site
Certain comorbid Axis I diagnoses, namely:
generalized SAD
schizophrenia or other psychotic disorder
current substance dependence
Comorbid diagnoses of Major Depressive or other mood or anxiety disorders are acceptable ONLY if clearly secondary to the diagnosis of public speaking anxiety

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00842946). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.